Rheumatic syndromes caused by antirheumatic drugs

Adachi, 1990, Bone densitometry, Journal of Rheumatology, 17, 419 Afifi, 1968, Steroid myopathy. Clinical, histological and cytologic observations, Johns Hopkins Medical Journal, 123, 158 Albright, 1943, Cushing's syndrome; its pathological physiology, Harvey Lectures, 38, 123 Aldrich, 1979, Effects of d-penicillamine on neuromuscular transmission in rats, Muscle and Nerve, 2, 180, 10.1002/mus.880020305 Allen, 1986, Intraarticular triamcinolone in the management of chronic arthritis in children, Arthritis and Rheumatism, 29, 997, 10.1002/art.1780290808 Amatruda, 1965, Certain endocrine and metabolic factors of the steroid withdrawal syndrome, Journal of Clinical Endocrinology and Metabolism, 25, 1207, 10.1210/jcem-25-9-1207 Ansell, 1983, Cytotoxic drugs for non-neoplastic disease, British Medical Journal, 287, 762, 10.1136/bmj.287.6394.762-a Argov, 1980, Neuromuscular transmission and acetylcholine receptor antibodies in rheumatoid arthritis patients on d-penicillamine, Lancet, i, 203, 10.1016/S0140-6736(80)90686-8 Arlet, 1972, Recherches cliniques sur la pression intra-osseuse dans la metaphyse et l'épiphyse fémorales supérieures chez l'homme. Application au diagnostic des ischemies et nécroses, Revue du Rhumatisme et des Maladies Ostéo-articulaires, 39, 717 Arora, 1968, Indomethacin arthropathy of the hips, Proceedings of the Royal Society of Medicine, 61, 689 Askari, 1976, Steroid myopathy in connective tissue disease, American Journal of Medicine, 61, 485, 10.1016/0002-9343(76)90327-2 Atcheson, 1978, Ptosis and weakness after start of d-penicillamine therapy, Annals of Internal Medicine, 89, 939, 10.7326/0003-4819-89-6-939 Atkinson, 1987, Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty, Bone Marrow Transplantation, 2, 421 Balch, 1977, Repeated corticosteroid injections into knee joints, Rheumatology and Rehabilitation, 16, 137, 10.1093/rheumatology/16.3.137 Bálint, 1975, Myasthenia gravis developed under d-penicillamine treatment, Scandinavian Journal of Rheumatology Bálint, 1984, Long term follow-up of 7 RA patients having developed myasthenia during d-penicillamine treatment Begg, 1964, Chloroquine neuromyopathy, British Medical Journal, i, 770, 10.1136/bmj.1.5385.770 Behan, 1973, Immune response genes in myasthenia gravis, Lancet, ii, 1033, 10.1016/S0140-6736(73)91130-6 Behrens, 1976, Metabolic recovery of articular cartilage after intra-articular injections of glucocorticoid, Journal of Bone and Joint Surgery, 58A, 1157, 10.2106/00004623-197658080-00023 Bensen, 1984, HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis, Journal of Rheumatology, 11, 358 Bentley, 1969, Disorganisation of the knee following intra-articular hydrocortisone injections, Journal of Bone and Joint Surgery, B51, 498, 10.1302/0301-620X.51B3.498 Benveniste, 1975, Pemphigus induit par la d-penicillamine dans la polyarthrite rheumatoide, La Nouvelle Presse Médicale, 4, 3125 Berger, 1990, Immediate ‘steroid flare’ from intra-articular triamcinolone hexacetonide. Case report and review of the literature, Arthritis and Rheumatism, 33, 1284, 10.1002/art.1780330833 Bergstein, 1974, Avascular necrosis of bone in systemic lupus erythematosus, Journal of Pediatrics, 85, 31, 10.1016/S0022-3476(74)80281-7 Bettendorf, 1974, Penicillamin induzierte Polymyositis, Deutsche Medizinische Wochenschrift, 99, 2513, 10.1055/s-0028-1108165 Bettendorf, 1975, Moschcowitz syndrome nach D-Penicillamin-Medikation, Medizinische Welt, 26, 291 Bever, 1982, Penicillamine induced myasthenia gravis. Effects of penicillamine on acetylcholine receptor, Neurology, 32, 1077, 10.1212/WNL.32.10.1077 Blodgett, 1956, Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children, New England Journal of Medicine, 254, 636, 10.1056/NEJM195604052541402 Blodgett, 1984, Auranofin: a unique oral chrysotherapeutic agent, Seminars in Arthritis and Rheumatism, 13, 255, 10.1016/0049-0172(84)90029-5 Boettcher, 1970, Nontraumatic necrosis of the femoral head: Part 2. Experience in treatment, Journal of Bone and Joint Surgery, 52A, 322, 10.2106/00004623-197052020-00013 Boksenbaum, 1963, Aseptic necrosis of the femoral head associated with steroid therapy, Journal of the American Medical Association, 184, 262, 10.1001/jama.1963.03700170054007 Bombelburg, 1989, Aseptic osteonecroses in the treatment of childhood acute leukaemias, European Journal of Pediatrics, 149, 20, 10.1007/BF02024327 Bonnarens, 1985, Bone scintigraphic changes in osteonecrosis of the femoral head, Orthopedic Clinics of North America, 16, 697, 10.1016/S0030-5898(20)30436-3 Bontoux, 1974, Complications neurologiques de la chrysothérapie. A propos de deux cas dont un syndrome de Guillain et Barré, Revue du Rhumatisme et des Maladies Ostéo-articulaires, 41, 48 Bowyer, 1985, Steroid myopathy: incidence and detection in a population with asthma, Journal of Allergy and Clinical Immunology, 76, 234, 10.1016/0091-6749(85)90708-0 Brousson, 1981, Polymyosite induite par la d-penicillamine, Revue du Rhumatisme et des Maladies Ostéo-articulaires, 48, 267 Bucknall, 1975, Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis, British Medical Journal, i, 600, 10.1136/bmj.1.5958.600 Bucknall, 1979, Myasthenia associated with d-penicillamine therapy in rheumatoid arthritis, Scandinavian Journal of Rheumatology, 91, 10.3109/03009747909108245 Burack, 1988, Hyperuricaemia and gouty arthritis among heart transplant patients treated with cyclosporin (Cy), Arthritis and Rheumatism, 31, 548 Butler, 1983, A new model of osteoarthritis in rabbits III. Evaluation of anti-osteoarthritic effects of selected drugs administered intra-articularly, Arthritis and Rheumatism, 26, 1380, 10.1002/art.1780261111 Caldron, 1987, Gold myokymia syndrome. A rare toxic manifestation of chrysotherapy, Cleveland Clinical Journal of Medicine, 54, 225, 10.3949/ccjm.54.3.225 Camus, 1976, Autoantibodies in d-penicillamine treated rheumatoid arthritis, Agents and Actions, 6, 351, 10.1007/BF01972254 Camus, 1981, Autoantibody formation in d-penicillamine treated rheumatoid arthritis, Journal of Rheumatology, 8, 80 Canalis, 1984, Effect of cortisol on periosteal and non-periosteal collagen and DNA synthesis in cultured rat calvariae, Calcified Tissue International, 36, 158, 10.1007/BF02405312 Carrano, 1983, An enzyme linked immunosorbent assay for antistriational antibodies associated with myasthenia gravis and thymoma. Comparison with indirect immunofluorescence, Journal of Immunological Methods, 13, 301, 10.1016/0022-1759(83)90191-6 Carroll, 1987, Penicillamine induced polymyositis and dermatomyositis, Journal of Rheumatology, 14, 995 Carter, 1984, La myasthénie au cours du traitement de la polyarthrite rhumatoide par la d-penicillamine, Thérapie, 39, 689 Cass, 1966, New bone formation in osteoporosis following treatment with sodium fluoride, Archives of Internal Medicine, 118, 111, 10.1001/archinte.1966.00290140015004 Chen, 1979, Glucocorticoid receptors and actions on subpopulations of cultured rat bone cells, Journal of Clinical Investigation, 63, 750, 10.1172/JCI109359 Chyun, 1984, Cortisol decreases bone formation by inhibiting periosteal cell proliferation, Endocrinology, 114, 477, 10.1210/endo-114-2-477 Clayton, 1974, Azathioprine in psoriasis, British Medical Journal, 443 Colombo, 1983, A new model of osteoarthritis in rabbits II. Evaluation of anti-osteoarthritic effects of selected antirheumatic drugs administered systemically, Arthritis and Rheumatism, 26, 1132, 10.1002/art.1780260911 Compston, 1980, Osteomalacia developing during treatment of osteoporosis with sodium fluoride and vitamin D, British Medical Journal, 281, 910, 10.1136/bmj.281.6245.910 Crouzet, 1974, Lupus induit par la d-penicillamine au cours du traitement de la polyarthrite rhumatoide, Annales de Médecine Interne, 125, 71 Cruess, 1977, Cortisone-induced avascular necrosis of the femoral head, Journal of Bone and Joint Surgery, 59B, 308, 10.1302/0301-620X.59B3.893509 Cruess, 1981, Steroid induced osteonecrosis, Journal of the Royal College of Surgeons of Edinburgh, 26, 69 Cruess, 1975, The etiology of steroid-induced avascular necrosis of bone. A laboratory and clinical study, Clinical Orthopaedics and Related Research, 113, 178, 10.1097/00003086-197511000-00028 Cucher, 1976, d-Penicillamine induced polymositis in rheumatoid arthritis, Annals of Internal Medicine, 85, 615, 10.7326/0003-4819-85-5-615 Curtess, 1954, Vertebral fractures resulting from prolonged cortisone and corticotrophin therapy, Journal of the American Medical Association, 156, 467, 10.1001/jama.1954.02950050007002 Cushing, 1932, The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism), Johns Hopkins Hospital Bulletin, 50, 137 Czlonkowska, 1975, Myasthenia syndrome during penicillamine treatment, British Medical Journal, ii, 726, 10.1136/bmj.2.5973.726-a D'Anglejan, 1985, Myasthénies induites par la d-pènicillamine, Presse Médicale, 14, 2336 Dawkins, 1975, Experimental autoallergic myositis, polymyositis and myasthenia gravis, Clinical and Experimental Immunology, 21, 185 Dawkins, 1975, Penicillamine therapy, antistriational antibody, and myasthenia gravis, British Medical Journal, iv, 759, 10.1136/bmj.4.5999.759-c Dawkins, 1981, Myasthenia gravis and d-penicillamine, Journal of Rheumatology, 8, 169 Dawkins, 1981, Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis, Annals of the New York Academy of Sciences, 377, 372, 10.1111/j.1749-6632.1981.tb33745.x Dawkins, 1981, Immunobiology of d-penicillamine, Journal of Rheumatology, 8, 56 Dawkins, 1987, Immunogenetics of spontaneous, drug-induced and experimental myasthenia gravis, Annals of the New York Academy of Sciences, 505, 398, 10.1111/j.1749-6632.1987.tb51310.x Delamere, 1983, Penicillamine induced myasthenia in rheumatoid arthritis: its clinical and genetic features, Annals of the Rheumatic Diseases, 42, 500, 10.1136/ard.42.5.500 Delrieu, 1976, Myasthénie et thyroidite autoimmune au cours du traitement de la polyarthrite rhumatoide par la d-penicillamine, Annales de Médecine Interne, 127, 739 Dempster, 1983, Mean wall thickness and formation periods of trabecular bone pockets in corticosteroid-induced osteoporosis, Calcified Tissue International, 35, 410, 10.1007/BF02405069 Dick, 1982, The Guillian-Barré syndrome following gold therapy, Scandinavian Journal of Rheumatology, 11, 119, 10.3109/03009748209098174 Dietrich, 1979, Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro, Endocrinology, 104, 715, 10.1210/endo-104-3-715 Dixon, 1964, L'indométacine un médicament actif pour la coxarthrose, Rhumatologie, 16, 449 Dixon, 1980, On the various forms of the corticosteroid withdrawal syndrome, American Journal of Medicine, 68, 224, 10.1016/0002-9343(80)90358-7 Dodd, 1980, Adverse reactions to d-penicillamine after gold toxicity, British Medical Journal, 280, 1498, 10.1136/bmj.280.6230.1498 Dougados, 1982, Polyradiculonévrite de la chrysothérapie, La Nouvelle Presse Médicale, 11, 1878 Downes, 1966, Auto-immune aspects of myasthenia gravis, Quarterly Journal of Medicine, 35, 85 Doyle, 1950, Severe polyneuritis following gold therapy for rheumatoid arthritis, Annals of Internal Medicine, 33, 1468, 10.7326/0003-4819-33-6-1468 Doyle, 1983, Fatal polymyositis in d-penicillamine-treated rheumatoid arthritis, Annals of Internal Medicine, 98, 327, 10.7326/0003-4819-98-3-327 Dubois, 1958, Triamcinolone in the treatment of systemic lupus erythematosus, Journal of the American Medical Association, 167, 1590, 10.1001/jama.1958.02990300016004 Earley, 1988, Triamcinolone into the knee joint in juvenile chronic arthritis, Clinical and Experimental Rheumatology, 6, 153 Ebringer, 1971, Chloroquine myopathy, British Medical Journal, ii, 770, 10.1136/bmj.2.5764.770-b Ebringer, 1967, Chloroquine neuromyopathy associated with keratopathy and retinopathy, British Medical Journal, i, 219, 10.1136/bmj.2.5546.219 Ellis, 1985, Steroid myopathy, Journal of Allergy and Clinical Immunology, 76, 431, 10.1016/0091-6749(85)90722-5 Eriksen, 1985, Effect of sodium fluoride, calcium, phosphate, and vitamin D on trabecular bone balance and remodelling in osteoporosis, Bone, 6, 381, 10.1016/8756-3282(85)90337-0 Essigman, 1982, Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis, Annals of the Rheumatic Diseases, 41, 617, 10.1136/ard.41.6.617 Estes, 1987, Chloroquine neuromyotoxicity. Clinical and pathologic perspective, American Journal of Medicine, 82, 447, 10.1016/0002-9343(87)90444-X Fam, 1984, Neurologic complications associated with gold therapy for rheumatoid arthritis, Journal of Rheumatology, 11, 700 Fawcett, 1982, d-Penicillamine associated myasthenia gravis: immunological and electrophysiological studies, Muscle and Nerve, 5, 328, 10.1002/mus.880050409 Feldman, 1975, Cytoplasmic glucocorticoid binding proteins in bone cells, Endocrinology, 96, 29, 10.1210/endo-96-1-29 Feltkamp, 1974, Myasthenia gravis, autoantibodies and HLA antigens, British Medical Journal, i, 131, 10.1136/bmj.1.5899.131 Ferbert, 1989, d-Penicillamin-induzierte okulare Myasthenie bei Psoriasisarthritis, Nervenarzt, 60, 576 Fernandes, 1977, Dermatomyositis complicating penicillamine treatment, Annals of the Rheumatic Diseases, 36, 94, 10.1136/ard.36.1.94 Finbloom, 1985, Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity, Journal of Rheumatology, 12, 692 Fisher, 1969, Histologic demonstration of fat emboli in aseptic necrosis, associated with hypercortisonism, Mayo Clinic Proceedings, 44, 252 Fitzgerald, 1976, Intrasynovial injection of steroids. Uses and abuses, Mayo Clinic Proceedings, 51, 655 Forestier, 1929, L'aurothérapie dans les rhumatismes chroniques, Bulletin et Memoires de la Société Médicale des Hôpitaux de Paris, 44, 323 Freyberg, 1958, Further experiences with 19 alpha-fluoro-16 hydroxyhydrocortisone (triamcinolone) in the treatment of patients with rheumatoid arthritis, Arthritis and Rheumatism, 1, 215, 10.1002/art.1780010304 Frost, 1961, The effect of cortisone on lamellar osteoblastic activity, Henry Ford Hospital Medical Journal, 9, 97 Furst, 1977, A double-blind trial of high versus conventional dosages of gold salt for rheumatoid arthritis, Arthritis and Rheumatism, 20, 1473, 10.1002/art.1780200805 Gallagher, 1984, Hormone target cell interactions in human bone, 431 Gambari, 1984, Neurotoxicity following a very high dose of oral gold (auranofin), Arthritis and Rheumatism, 11, 1316, 10.1002/art.1780271121 Garlepp, 1982, Polymyositis, 256 Garlepp, 1983, HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis, British Medical Journal, 286, 338, 10.1136/bmj.286.6362.338 George, 1984, Myasthenic pseudo-internuclear ophthalmoplegia due to penicillamine, Journal of Neurology, Neurosurgery and Psychiatry, 47, 1044, 10.1136/jnnp.47.9.1044 Gibson, 1976, Goodpasture syndrome and d-penicillamine, Annals of Internal Medicine, 84, 100, 10.7326/0003-4819-84-1-100_1 Gilsanz, 1984, Joint calcification following intra-articular corticosteroid therapy, Radiology, 151, 647, 10.1148/radiology.151.3.6718724 Glyn, 1966, Low incidence of osteoarthrosis in hip and knee after anterior poliomyelitis: a late review, British Medical Journal, ii, 739, 10.1136/bmj.2.5516.739 Good, 1959, Symptomatology resulting from withdrawal of steroid hormone therapy, Arthritis and Rheumatism, 2, 299, 10.1002/1529-0131(195908)2:4<299::AID-ART1780020403>3.0.CO;2-T Gordon, 1989, Gold compounds, 804 Gordon, 1979, Management of gout, American Family Physician, 19, 91 Gordon, 1977, d-Penicillamine-induced myasthemia gravis in rheumatoid arthritis, Annals of Internal Medicine, 87, 578, 10.7326/0003-4819-87-5-578 Gran, 1983, HLA DR antigens and gold toxicity, Annals of the Rheumatic Diseases, 42, 63, 10.1136/ard.42.1.63 Gray, 1981, Local corticosteroid injection treatment in rheumatic disorders, Seminars in Arthritis and Rheumatism, 10, 231, 10.1016/0049-0172(81)90001-9 Gronowicz, 1988, Effects of corticosterone and parathyroid hormone in formation and resorption in cultured fetal rat parietal bones, Journal of Bone and Mineral Research, 3, S114 Hahn, 1978, Corticosteroid induced osteopenia, Archives of Internal Medicine, 138, 882, 10.1001/archinte.138.Suppl_5.882 Halla, 1977, Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts, Arthritis and Rheumatism, 20, 1188, 10.1002/art.1780200605 Halla, 1984, Penicillamine-induced myositis, American Journal of Medicine, 77, 719, 10.1016/0002-9343(84)90371-1 Harber, 1985, Thigh muscle mass and function in patients treated with glucocorticoids, European Journal of Clinical Investigation, 15, 302, 10.1111/j.1365-2362.1985.tb00276.x Harber, 1985, Evidence that prednisone-induced myopathy is reversed by physical training, Journal of Clinical Endocrinology and Metabolism, 61, 83, 10.1210/jcem-61-1-83 Hardin, 1979, Controlled study of the long term effects of ‘total hand’ injection, Arthritis and Rheumatism, 22, 619 Harper, 1984, Avascular necrosis of bone caused by combination chemotherapy without corticosteroids, British Medical Journal, 288, 267, 10.1136/bmj.288.6413.267 Harpey, 1971, Lupus like syndrome induced by d-penicillamine in Wilson's disease, Lancet, i, 292, 10.1016/S0140-6736(71)91022-1 Harter, 1963, Studies on an intermittent corticosteroid dosage regimen, New England Journal of Medicine, 269, 591, 10.1056/NEJM196309192691201 Heaney, 1989, Fluoride therapy for the vertebral crush fracture syndrome: a status report, Annals of Internal Medicine, 111, 678, 10.7326/0003-4819-111-8-678 Hedlund, 1989, Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride, Journal of Bone and Mineral Research, 4, 223, 10.1002/jbmr.5650040214 Heimann, 1960, Avascular necrosis of the femoral and humeral heads after high-dosage corticosteroid therapy, New England Journal of Medicine, 263, 72, 10.1056/NEJM196010062631404 Herman, 1986, The in vitro effect of select classes of nonsteroidal antiinflammatory drugs on normal cartilage metabolism, Journal of Rheumatology, 13, 1014 Hess, 1986, Cartilage metabolism and anti-inflammatory drugs in osteoarthritis, American Journal of Medicine, 81, 36 Hollander, 1970, Intrasynovial corticosteroid therapy in arthritis, Maryland Medical Journal, 19, 62 Hollander, 1961, Intrasynovial corticosteroid therapy: a decade of use, Bulletin on the Rheumatic Diseases, 11, 239 Horwitz, 1949, Muscle lesions in rheumatoid arthritis, Annals of the Rheumatic Diseases, 8, 258, 10.1136/ard.8.4.258 Hughes, 1971, Chloroquine myopathy, Quarterly Journal of Medicine, 40, 85 Hungerford, 1979, Bone marrow pressure, venography and core decompression in ischaemic necrosis of the femoral head Hungerford, 1978, Alcoholism-associated ischaemic necrosis of the femoral head, Clinical Orthopaedics and Related Research, 130, 144 Husain, 1980, Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, d-penicillamine and levamisole, Journal of Rheumatology, 7, 825 Huskisson, 1990, Clinical aspects of chondroprotection, Seminars in Arthritis and Rheumatism, 19, 30, 10.1016/0049-0172(90)90083-R Huskisson, 1979, Another look at osteoarthritis, Annals of the Rheumatic Diseases, 38, 423, 10.1136/ard.38.5.423 Huskisson, 1985, Drug treatment of osteoarthritis, Clinics in Rheumatic Diseases, 11, 421, 10.1016/S0307-742X(21)00548-8 Ihde, 1975, Osteonecrosis of thefemoral head in patients with lymphoma treated with intermittent combination chemotherapy, Cancer, 36, 1585, 10.1002/1097-0142(197511)36:5<1585::AID-CNCR2820360508>3.0.CO;2-D Jaffe, 1989, Penicillamine, 829 Jakobus, 1976, d-Penicillamine in the monkey, 25 Jalava, 1990, Periarticular calcification after intra-articular triamcinolone hexacetonide, Scandinavian Journal of Rheumatology, 9, 190, 10.3109/03009748009098157 Jee, 1972, Interrelated effects of glucocorticoid and parathyroid hormone on bone remodelling, 430 Job-Deslandre, 1990, Complications of intra-articular injections of triamcinolone hexacetonide in chronic arthritis in children, Clinical and Experimental Rheumatology, 8, 413 Johnson, 1964, Histogenesis of avascular necrosis Jones, 1978, Osteonecrosis, Clinical Orthopaedics and Related Research, 130, 5 Jones, 1965, Fat embolization as a possible mechanism producing avascular necrosis, Arthritis and Rheumatism, 8, 449 Kahl, 1986, Severe arthralgias after wide fluctuation in corticosteroid dosage, Journal of Rheumatology, 13, 1063 Kahl, 1989, Gout in the heart transplant recipient: physiologic puzzle and therapeutic challenge, American Journal of Medicine, 87, 289, 10.1016/S0002-9343(89)80153-6 Kean, 1985, The history of gold therapy in rheumatoid disease, Seminars in Arthritis and Rheumatism, 14, 180, 10.1016/0049-0172(85)90037-X Kenzora, 1985, Treatment of idiopathic osteonecrosis: the current philosphy and rationale, Orthopedic Clinics of North America, 16, 717, 10.1016/S0030-5898(20)30438-7 Kerrebijn, 1968, Effect of corticosteroid therapy on height in asthmatic children, Archives of Disease in Childhood, 43, 556, 10.1136/adc.43.231.556 Knox, 1986, Acute hydrocortisone myopathy in acute severe asthma, Thorax, 41, 411, 10.1136/thx.41.5.411 Kolarz, 1986, Azetylcholin-Rezeptorantikorper unter D-Penicillamintherapie, Zeitschrift für Rheumatologie, 45, 118 Kurlana, 1961, 307 Lam, 1968, Long term dwarfing effects of corticosteroid treatment for childhood nephrosis, Archives of Disease in Childhood, 43, 589, 10.1136/adc.43.231.589 Lang, 1981, Plasma exchange therapy for severe penicillamine induced myasthenia gravis, Journal of Rheumatology, 8, 303 Laroche, 1990, Osteonecrosis of the femoral and humeral heads after intra-articular corticosteroid injections, Journal of Rheumatology, 17, 549 Lawrence, 1976, Comparative toxicity of gold preparations in treatment of rheumatoid arthritis, Annals of the Rheumatic Diseases, 35, 171, 10.1136/ard.35.2.171 Leddy, 1975, Hereditary complement (C2) deficiency with dermatomyositis, American Journal of Medicine, 58, 83, 10.1016/0002-9343(75)90537-9 Lee, 1957, Avulsion and rupture of tendocalcaneus after injection of hydrocortisone, British Medical Journal, ii, 395, 10.1136/bmj.2.5041.395 Lee, 1973, Adverse reactions in patients with rheumatic diseases. Retrospective analysis of causes of admissions and outpatient attendance in a specialist centre, Annals of the Rheumatic Diseases, 32, 565, 10.1136/ard.32.6.565 Lennon, 1975, Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs, Journal of Experimental Medicine, 141, 1365, 10.1084/jem.141.6.1365 Lequesne, 1990, Les anti inflammatoires non steroidiens aggravent—ils la coxarthrose?, 311 Lequesne, 1989, La coxopathie destructrice rapide idiopathique. Étude étiologique prospective de 27 cas, Revue du Rhumatisme et des Maladies Ostéo-articulaires, 56, 115 Liddle, 1989, Development of morphea in rheumatoid arthritis treated with penicillamine, Annals of the Rheumatic Diseases, 48, 963, 10.1136/ard.48.11.963 Lin, 1989, Cyclosporin induced hyperuricaemia and gout, New England Journal of Medicine, 321, 287, 10.1056/NEJM198908033210504 Lipsky, 1980, Inhibition of human helper T cell function in vitro by d-penicillamine and CuSO4, Journal of Clinical Investigation, 65, 1069, 10.1172/JCI109759 Livingstone, 1961, Steroids in the long term treatment of asthma, Lancet, i, 1310, 10.1016/S0140-6736(61)90238-0 Lossner, 1989, Sekunder muskularer carnitinmangel nach immunsuppressiver behandlung, Psychiatrie, Neurologie und Medizinische Psychologie, 41, 614 Lucas, 1990, Douleurs osseuses epiphysais rapportées a la ciclosporine A chez 28 transplantés rénaux, Revue du Rhumatisme et des Maladies Osteoarticulaires, 57, 79 Lukert, 1990, Glucocorticoid-induced osteoporosis: pathogenesis and management, Annals of Internal Medicine, 112, 352, 10.7326/0003-4819-112-5-352 Lund, 1985, Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long term glucocorticoid treatment, Clinical Rheumatology, 4, 143, 10.1007/BF02032284 Maier, 1984, Preclinical investigations of drug effect in models of osteoarthrosis, 90 Maigne, 1988, Les traitements locaux dans l'arthrite chronique juvénile, Annales de Pediatrie, 151, 647 Mankin, 1966, The acute effects of intra-articular hydrocortisone on articular cartilage in rabbit, Journal of Bone and Joint Surgery, 48A, 1383, 10.2106/00004623-196648070-00012 Marcus, 1984, d-Penicillamine induced myasthenia gravis in primary biliary cirrhosis, Gastroenterology, 86, 166, 10.1016/0016-5085(84)90604-8 Martin, 1967, Methotrexate in psoriasis, Archives of Dermatology, 96, 431, 10.1001/archderm.1967.01610040081015 Martin, 1980, Anti-acetylcholine receptor antibodies in penicillamine treated patients without myasthenia gravis, Lancet, ii, 705, 10.1016/S0140-6736(80)92753-1 Marymont, 1986, Osteonecrosis of bone associated with combination chemotherapy without corticosteroids, Clinical Orthopaedics and Related Research, 204, 150, 10.1097/00003086-198603000-00016 Masters, 1977, Penicillamine-associated myasthenia gravis, anti-acetylcholine receptor and antistriational antibodies, American Journal of Medicine, 63, 689, 10.1016/0002-9343(77)90153-X May, 1977, Syndrome de Gougerot-Sjögren induit par la d-penicillamine, Revue du Rhumatisme et des Maladies Ostéo-articulaires, 44, 497 McCarty, 1972, Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide, Arthritis and Rheumatism, 15, 157, 10.1002/art.1780150205 McCarty, 1985, 1494 McCarty, 1964, Inflammatory reaction after intra-synovial injection of microcrystalline adrenocorticosteroid esters, Arthritis and Rheumatism, 7, 359, 10.1002/art.1780070402 McFarlane, 1977, Severe myopathy after status asthmaticus, Lancet, ii, 615, 10.1016/S0140-6736(77)91471-4 McKenzie, 1976, Effect of antiinflammatory drugs on sulphated glycosaminoglycan synthesis in aged human cartilage, Annals of the Rheumatic Diseases, 35, 487, 10.1136/ard.35.6.487 McLachlan, 1983, d-Penicillamine associated myasthenia gravis, Muscle and Nerve, 6, 170 Medsger, 1970, The epidemiology of polymyositis, American Journal of Medicine, 48, 715, 10.1016/S0002-9343(70)80006-7 Merle d'Aubigne, 1965, Idiopathic necrosis of the femoral head in adults, Journal of Bone and Joint Surgery, 47B, 612, 10.1302/0301-620X.47B4.612 Meyers, 1988, Osteonecrosis of the femoral head. Pathogenesis and long-term results of treatment, Clinical Orthopaedics and Related Research, 231, 51, 10.1097/00003086-198806000-00005 Michel, 1990, Plain radiographs can be useful in estimating bone density, Journal of Rheumatology, 17, 528 Milner, 1973, Osteoarthritis of the hip and indomethacin, Journal of Bone and Joint Surgery, 54B, 752 Mjolnerod, 1971, Congenital connective tissue defect probably due to d-penicillamine treatment in pregnancy, Lancet, i, 673, 10.1016/S0140-6736(71)92681-X Moore, 1984, Penicillamine induced myasthenia reactivated by gold, British Medical Journal, 288, 192, 10.1136/bmj.288.6412.192-a Morimoto, 1983, Direct demonstration of the human suppressor inducer subset by anti-T cell antibodies, Journal of Immunology, 130, 157, 10.4049/jimmunol.130.1.157 Morimoto, 1985, The isolation and characterization of the human suppressor inducer T-cell subset, Journal of Immunology, 134, 1508, 10.4049/jimmunol.134.3.1508 Narod, 1985, Economic and social burden of osteoporosis, 13 Navarro, 1986, Leukocytoclastic vasculitis after high-dose methotrexate, Annals of Internal Medicine, 105, 471, 10.7326/0003-4819-105-3-471_3 Nesbit, 1976, Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal system, Cancer, 37, 1048, 10.1002/1097-0142(197602)37:2+<1048::AID-CNCR2820370811>3.0.CO;2-V Newman, 1985, Acetabular bone destruction related to non-steroidal anti-inflammatory drugs, Lancet, ii, 11, 10.1016/S0140-6736(85)90058-3 Nietfeld, 1990, The effect of human IL-1 on proteoglycan metabolism in human and porcine cartilage expalnts, Journal of Rheumatology, 17, 818 Niotshikai, 1980, Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-I antibody system, Arthritis and Rheumatism, 23, 881, 10.1002/art.1780230802 Niotshikai, 1974, Monoclonal gammopathy, penicillamineinduced polymyositis and systemic sclerosis, Archives of Dermatology, 110, 253, 10.1001/archderm.1974.01630080051014 Noordzij, 1990, Cyclosoporin induced hyperuricaemia and gout, New England Journal of Medicine, 322, 334, 10.1056/NEJM199002013220514 Noppen, 1987, Cyclosporin and myopathy, Annals of Internal Medicine, 107, 945, 10.7326/0003-4819-107-6-945_3 Norman, 1963, The radiolucent cresent line—an early diagnostic sign of avascular necrosis of the femoral head, Bulletin for the Hospital of Joint Diseases, 24, 99 Obrist, 1978, Osteonecrosis after chemotherapy, Lancet, i, 1316, 10.1016/S0140-6736(78)91306-5 O'Keefe, 1985, Penicillamine induced ocular myasthenia gravis, American Journal of Ophthalmology, 99, 66, 10.1016/S0002-9394(14)75869-6 Oosterhuis, 1968, Rheumatic diseases in patients with myasthenia gravis. An epidemiological and clincial investigation, Acta Neurologica Scandinavica, 44, 219, 10.1111/j.1600-0404.1968.tb05568.x Ostensen, 1980, Polymyositis with acute myolysis in a patient with rheumatoid arthritis treated with penicillamine and ampicillin, Arthritis and Rheumatism, 23, 375, 10.1002/art.1780230322 Ott, 1974, Die Behandlung mit d-Penicillamin bei Rheumatoider Arthritis, Internist, 15, 328 Panayi, 1980, Genetic predisposition to gold and penicillamine induced drug toxicity, Scandinavian Journal of Rheumatology, 9 Panayi, 1983, Deficient sulphoxidation status and d-penicillamine toxicity, Lancet, i, 414, 10.1016/S0140-6736(83)91526-X Parkinson, 1977, Complications of cancer immunotherapy with levamisole, Lancet, ii, 1129, 10.1016/S0140-6736(77)92386-8 Patterson, 1964, Idiopathic avascular necrosis of the head of the femur. A study of 52 cases, Journal of Bone and Joint Surgery, 46A, 267, 10.2106/00004623-196446020-00004 Paulus, 1985, Aspirin and other nonsteroidal anti-inflammatory, drugs, 453 Peck, 1967, Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cells in vitro, Proceedings of the National Academy of Sciences of the USA, 57, 1599, 10.1073/pnas.57.6.1599 Pelletier, 1989, Evidence for the involvement of interleukin 1 in human OA cartilage degradation; protective effect of NSAID, Journal of Rheumatology, 16, 19 Petersen, 1978, Penicillamine induced polymyositis-dermatomyositis, Scandinavian Journal of Rheumatology, 7, 114, 10.3109/03009747809098847 Pietrograndi, 1957, Osteopatia da prolungato trattamento cortisonico, Ortopedia Y Traumatologia, 25, 791 Pitkeathly, 1966, Polymyositis in rheumatoid arthritis, Annals of the Rheumatic Diseases, 25, 127, 10.1136/ard.25.2.127 Powell, 1969, Steroid and hypokalaemic myopathy after corticosteroids for ulcerative colitis, American Journal of Gastroenterology, 52, 425 Ragab, 1989, Effect of nonsteroidal antiinflammatory drugs on the course of osteoarthritis, Lancet, ii, 519 Reeback, 1979, Penicillamine-induced neuromyotonia, British Medical Journal, i, 1464, 10.1136/bmj.1.6176.1464 Rees, 1988, Growth and endocrine function in steroid sensitive nephrotic syndrome, Archives of Disease in Childhood, 63, 484, 10.1136/adc.63.5.484 Reid, 1989, Steroid osteoporosis, Calcified Tissue International, 45, 63, 10.1007/BF02561402 Reid, 1985, Plasma testosterone concentrations in asthmatic men treated with glucocorticoids, British Medical Journal, 291, 574, 10.1136/bmj.291.6495.574 Reid, 1986, The effects of hydrocortisone, parathyroid hormone and the bisphosphonate APD on bone resorption in neonatal mouse calvaria, Calcified Tissue International, 38, 38, 10.1007/BF02556593 Riggs, 1984, Treatment of osteoporosis with sodium fluoride: an appraisal, 366 Riggs, 1990, Effect of fluoride treatment on the fracture rate in post menopausal women with osteoporosis, New England Journal of Medicine, 322, 802, 10.1056/NEJM199003223221203 Robberecht, 1989, Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction, Archives of Neurology, 46, 464, 10.1001/archneur.1989.00520400124033 Ronningeu, 1979, Indomethacin treatment in osteoarthritis of the hip joint, Acta Orthopaedica Scandinavica, 50, 169, 10.3109/17453677908989752 Roquer, 1985, Miller-Fischer syndrome, (Guillain-Barré syndrome with ophthalmoplegia) during treatment with gold salts in a patient with rheumatoid arthritis, Arthritis and Rheumatism, 28, 838, 10.1002/art.1780280723 Rosenberg, 1958, Rheumatoid arthritis, osteoporosis and fractures related to steroid therapy, Acta Medica Scandinavica, 211, 10.1111/j.0954-6820.1958.tb19112.x Rotstein, 1957, Steroid pseudorheumatism, Archives of Internal Medicine, 99, 545, 10.1001/archinte.1957.00260040045005 Russel, 1978, Penicillamine induced myasthenia gravis associated with antibodies to acetylcholine receptor, Neurology, 28, 847, 10.1212/WNL.28.8.847 Rynes, 1989, Antimalarial drugs, 792 Sartoris, 1989, Dual energy radiographic absorptiometry for bone densitometry: current status and perspective, American Journal of Radiology, 152, 241 Scadding, 1983, D-Penicillamine associated myasthenia gravis, Muscle and Nerve, 6, 170, 10.1002/mus.880060216 Schlumpf, 1983, Neurologic complications induced by gold treatment, Arthritis and Rheumatism, 26, 825, 10.1002/art.1780260702 Schraeder, 1972, Polymyositis and penicillamine, Archives of Neurology, 27, 456, 10.1001/archneur.1972.00490170088013 Schumm, 1981, Myasthenie-Syndrom unter Chloroquin-Therapie, Deutsche Medizinische Wochenschrift, 106, 1745, 10.1055/s-2008-1070589 Schwartz, 1984, Methotrexate osteopathy, Skeletal Radiology, 11, 13, 10.1007/BF00361126 Segal, 1977, Levamisole induced arthritis in Crohn's disease, British Medical Journal, ii, 555, 10.1136/bmj.2.6086.555 Segal, 1988, Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid rathritis, Arthritis and Rheumatism, 31, 1182, 10.1002/art.1780310915 Seitz, 1976, Penicillamin-induzierte Myasthenie bei chronischer Polyarthritis, Deutsche Medizinische Wochenschrift, 101, 1153, 10.1055/s-0028-1104232 Sevitt, 1965, The distribution and anastomoses of arteries supplying the head and neck of the femur, Journal of Bone and Joint Surgery, 47B, 560, 10.1302/0301-620X.47B3.560 Sghirlanzoni, 1988, Chloroquine myopathy and myasthenia-like syndrome, Muscle and Nerve, 11, 114, 10.1002/mus.880110205 Shubin, 1965, Long term administration of corticosteroids in pulmonary disease, Diseases of the Chest, 48, 287, 10.1378/chest.48.3.287 Sigidin, 1977, Neurological complication of levamisole, Lancet, ii, 980, 10.1016/S0140-6736(77)90918-7 Siklos, 1977, Levamisole-induced arthritis, British Medical Journal, ii, 773, 10.1136/bmj.2.6089.773-b Simpson, 1983, Role of d-penicillamine for the induction of myasthenia gravis, European Neurology, 22, 272, 10.1159/000115571 Simpson, 1966, Myasthenia gravis as an autoimmune disease: clinical aspects, Annals of the New York Academy of Sciences, 135, 506, 10.1111/j.1749-6632.1966.tb45499.x Skosey, 1985, Gold compounds, 487 Slocumb, 1953, Rheumatic complaints during chronic hypercortisonism and syndromes during withdrawal of cortisone in rheumatic patients, Mayo Clinic Proceedings, 28, 655 Smith, 1982, Influence of previous gold toxicity on subsequent development of penicillamine toxicity, British Medical Journal, 285, 595, 10.1136/bmj.285.6342.595 Solomon, 1973, Drug induced arthropathy and necrosis of the femoral head, Journal of Bone and Joint Surgery, 55B, 246, 10.1302/0301-620X.55B2.246 Solomon, 1985, Mechanisms of idiopathic osteonecrosis, Orthopedic Clinics of North America, 16, 655, 10.1016/S0030-5898(20)30433-8 Sparling, 1990, Radiographic followup of joints injected with triamcinolone hexacetonide for the management of childhood arthritis, Arthritis and Rheumatism, 33, 821, 10.1002/art.1780330608 Springfield, 1978, Surgery for aseptic necrosis of the femoral head, Clinical Orthopaedics and Related Research, 130, 175 Steen, 1986, The toxicity of d-penicillamine in systemic sclerosis, Annals of Internal Medicine, 104, 699, 10.7326/0003-4819-104-5-699 Steiner, 1946, Lesions of skeletal muscles in rheumatoid arthritis. Nodular polymyositis, American Journal of Pathology, 22, 103 Sternlieb, 1975, d-Penicillamine induced Goodpasture's syndrome in Wilson's disease, Annals of Internal Medicine, 82, 673, 10.7326/0003-4819-82-5-673 Stockman, 1986, Genetic markers in rheumatoid arthritis relationship to toxicity from d-penicillamine, Journal of Rheumatology, 13, 269 Stolzer, 1962, Intra-articular injections of adrenocorticosteroids in patients with arthritis, Pennsylvania Medical Journal, 65, 11 Sturrock, 1974, Penicillamine and creaking joints, British Medical Journal, iii, 575, 10.1136/bmj.3.5930.575 Sundstrom, 1979, Penicillamine induced myasthenia gravis, Arthritis and Rheumatism, 22, 197, 10.1002/art.1780220214 Swartz, 1984, d-Penicillamine induced polymyositis in juvenile chronic arthritis: report of a case, Journal of Rheumatology, 11, 251 Sweet, 1976, Avascular necrosis of the femoral head with combination therapy, Annals of Internal Medicine, 85, 67, 10.7326/0003-4819-85-1-67 Sweetnam, 1969, Corticosteroid arthropathy and tendon rupture, Journal of Bone and Joint Surgery, 51B, 397, 10.1302/0301-620X.51B3.397 Szobor, 1979, Development of myasthenia gravis in penicillamine treated rheumatoid arthritis patients, Hungarian Rheumatology, 28 Takahashi, 1986, d-Penicillamine induced polymyositis in patients with rheumatoid arthritis, Arthritis and Rheumatism, 29, 560, 10.1002/art.1780290416 Thirupathi, 1984, Sparing effect of tendon injury on osteoarthritis, Journal of Hand Surgery, 9, 592, 10.1016/S0363-5023(84)80119-7 Tiller, 1985, Gout and hyperuricaemia in patients on cyclosporin and diuretics, Lancet, i, 453, 10.1016/S0140-6736(85)91166-3 Torres, 1980, Penicillamine-induced myasthenia gravis in progressive systemic sclerosis, Arthritis and Rheumatism, 23, 505, 10.1002/art.1780230414 Tzartos, 1988, Fine antigenic specificities of antibodies in sera from patients with d-penicillamine-induced myasthenia gravis, Clinical and Experimental Immunology, 74, 80 Unterman, 1985, Glucocorticoid effects on somatomedins and somatomedin inhibitors, Journal of Clinical Endocrinology and Metabolism, 61, 618, 10.1210/jcem-61-4-618 Vakil, 1989, Steroid-related osteonecrosis in inflammatory bowel disease, Gastroenterology, 96, 62, 10.1016/0016-5085(89)90764-6 Van Marle, 1980, Acute hydrocortisone myopathy, British Medical Journal, 281, 271, 10.1136/bmj.281.6235.271-a Verbruggen, 1989, Proteoglycan metabolism in tissuecultured human articular cartilage: influence of piroxicam, Journal of Rheumatology, 16, 355 Vernay, 1986, ‘Chorée fibrillaire de Morvan’ followed by Guillain-Barré syndrome in a patient receiving gold therapy, Arthritis and Rheumatism, 29, 1413, 10.1002/art.1780291119 Vignon, 1990, Cartilage degradative enzymes in human osteoarthritis: effect of a nonsteroidal antiinflammatory drug administered orally, Seminars in Arthritis and Rheumatism, 19, 26, 10.1016/0049-0172(90)90082-Q Vincent, 1982, Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine induced myasthenia or idiopathic myasthenia of recent onset, Clinical and Experimental Immunology, 49, 266 Vincent, 1983, HLA antigens in penicillamine induced myasthenia gravis, British Medical Journal, 286, 893, 10.1136/bmj.286.6368.893-b Vincent, 1978, Anti-acetylcholine receptor antibodies in d-penicillamine-associated myasthenia gravis, Lancet, i, 1254, 10.1016/S0140-6736(78)92481-9 Waller, 1965, Connective tissue disease and rheumatoid factors in patients with renal transplants, New England Journal of Medicine, 273, 12, 10.1056/NEJM196507012730103 Watson, 1976, Femoral head height loss: a study of the relative significance of some of its determinants in hip degeneration, Rheumatology and Rehabilitation, 15, 264, 10.1093/rheumatology/15.4.264 Webley, 1978, Is penicillamine therapy in rheumatoid arthritis influenced by previous treatment with gold?, British Medical Journal, 281, 1 Weeden, 1990, Cyclosporin induced hyperuricaemia and gout, New England Journal of Medicine, 322, 335 Weiner, 1989, Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a re-evaluation, Journal of Rheumatology, 16, 604 Weiss, 1990, Corticosteroids in rheumatoid arthritis, Seminars in Arthritis and Rheumatism, 19, 9, 10.1016/0049-0172(89)90083-8 Whisnant, 1963, Chloroquine neuropathy, Proceedings of the Staff Meetings of the Mayo Clinic, 38, 501 Wilkens, 1975, Treatment of gout with naproxen, Journal of Clinical Pharmacology, 15, 353, 10.1002/j.1552-4604.1975.tb01465.x Williams, 1983, Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality, Thorax, 38, 813, 10.1136/thx.38.11.813 Williams, 1985, Benoxaprofen reduces osteophyte formation and fibrillation after articular cartilage injury, Journal of Rheumatology, 12, 27 Wysocka, 1981, Myasthenia gravis as a complication of d-penicillamine therapy in rheumatoid arthritis, Zeitschrift für Rheumatologie, 40, 135 Wojnarowska, 1980, Dermatomyositis induced by penicillamine, Journal of the Royal Society of Medicine, 73, 884, 10.1177/014107688007301213 Wolf, 1966, Myasthenia as an autoimmune disease: clinical aspects, Annals of the New York Academy of Sciences, 135, 517, 10.1111/j.1749-6632.1966.tb45500.x Wooley, 1980, HLA-DR antigens and toxic reaction to sodium aurothiomalate and d-penicillamine in patients with rheumatoid arthritis, New England Journal of Medicine, 303, 300, 10.1056/NEJM198008073030602 Yates, 1971, Steroid myopathy, Rheumatology and Physical Medicine, 11, 28, 10.1093/rheumatology/11.1.28 Yu, 1959, A study of the paradoxical effects of salicylate in low intermediate and high dosage on the renal mechanism for the excretion of urate in man, Journal of Clinical Investigation, 38, 1298, 10.1172/JCI103905 Zizic, 1980, Ischaemic bone necrosis in systemic lupus erythematosus. Part 2. The early diagnosis of ischaemic necrosis of bone, Medicine, 59, 134, 10.1097/00005792-198003000-00004 Zizic, 1985, Corticosteroid therapy associated with ischaemic necrosis of bone in systemic lupus erythematosus, American Journal of Medicine, 79, 596, 10.1016/0002-9343(85)90057-9